Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1485376rdf:typepubmed:Citationlld:pubmed
pubmed-article:1485376lifeskim:mentionsumls-concept:C0031327lld:lifeskim
pubmed-article:1485376lifeskim:mentionsumls-concept:C0038425lld:lifeskim
pubmed-article:1485376lifeskim:mentionsumls-concept:C0681916lld:lifeskim
pubmed-article:1485376lifeskim:mentionsumls-concept:C0750572lld:lifeskim
pubmed-article:1485376lifeskim:mentionsumls-concept:C0680844lld:lifeskim
pubmed-article:1485376pubmed:issue6lld:pubmed
pubmed-article:1485376pubmed:dateCreated1993-2-18lld:pubmed
pubmed-article:1485376pubmed:abstractTextStreptomycin dose requirements were determined in an 83-year-old man with renal impairment who was being treated for miliary tuberculosis. Concentration measurements were interpreted using a Bayesian parameter estimation program. Estimated creatinine clearance (1.1 L/h) was used as a starting value for streptomycin clearance, and volume was initially assumed to be 0.3 L/kg. Bayesian estimates of clearance were close to the starting value and declined from 1.4 L/h to 0.9 L/h during the course of therapy. Volume was higher than the initial estimate (0.4-0.5 L/kg), possibly due to the patient having a low albumin and being underweight. Satisfactory concentrations were maintained for several weeks with doses of 500 mg every 36-48 h.lld:pubmed
pubmed-article:1485376pubmed:languageenglld:pubmed
pubmed-article:1485376pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1485376pubmed:citationSubsetIMlld:pubmed
pubmed-article:1485376pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1485376pubmed:statusMEDLINElld:pubmed
pubmed-article:1485376pubmed:monthDeclld:pubmed
pubmed-article:1485376pubmed:issn0163-4356lld:pubmed
pubmed-article:1485376pubmed:authorpubmed-author:GordonJJlld:pubmed
pubmed-article:1485376pubmed:authorpubmed-author:CooteJJlld:pubmed
pubmed-article:1485376pubmed:authorpubmed-author:ThomsonA HAHlld:pubmed
pubmed-article:1485376pubmed:authorpubmed-author:MacPhersonLLlld:pubmed
pubmed-article:1485376pubmed:issnTypePrintlld:pubmed
pubmed-article:1485376pubmed:volume14lld:pubmed
pubmed-article:1485376pubmed:ownerNLMlld:pubmed
pubmed-article:1485376pubmed:authorsCompleteYlld:pubmed
pubmed-article:1485376pubmed:pagination522-4lld:pubmed
pubmed-article:1485376pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:1485376pubmed:meshHeadingpubmed-meshheading:1485376-...lld:pubmed
pubmed-article:1485376pubmed:meshHeadingpubmed-meshheading:1485376-...lld:pubmed
pubmed-article:1485376pubmed:meshHeadingpubmed-meshheading:1485376-...lld:pubmed
pubmed-article:1485376pubmed:meshHeadingpubmed-meshheading:1485376-...lld:pubmed
pubmed-article:1485376pubmed:meshHeadingpubmed-meshheading:1485376-...lld:pubmed
pubmed-article:1485376pubmed:meshHeadingpubmed-meshheading:1485376-...lld:pubmed
pubmed-article:1485376pubmed:meshHeadingpubmed-meshheading:1485376-...lld:pubmed
pubmed-article:1485376pubmed:year1992lld:pubmed
pubmed-article:1485376pubmed:articleTitleBayesian estimation of streptomycin pharmacokinetics.lld:pubmed
pubmed-article:1485376pubmed:affiliationDepartment of Medicine and Therapeutics, Western Infirmary, Glasgow, Scotland.lld:pubmed
pubmed-article:1485376pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1485376pubmed:publicationTypeCase Reportslld:pubmed